423 related articles for article (PubMed ID: 11389067)
61. Polymorphisms in metabolizing enzymes and the risk of head and neck squamous cell carcinoma in the Slavic population of the central Europe.
Soucek P; Susova S; Mohelnikova-Duchonova B; Gromadzinska J; Moraviec-Sztandera A; Vodicka P; Vodickova L
Neoplasma; 2010; 57(5):415-21. PubMed ID: 20568895
[TBL] [Abstract][Full Text] [Related]
62. GSTM1 and GSTT1 genes analysis in head and neck cancer patients.
Leme CV; Raposo LS; Ruiz MT; Biselli JM; Galbiatti AL; Maniglia JV; Pavarino-Bertelli EC; Goloni-Bertollo EM
Rev Assoc Med Bras (1992); 2010; 56(3):299-303. PubMed ID: 20676536
[TBL] [Abstract][Full Text] [Related]
63. Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Mishra BN; Pant MC; Parmar D
Mutat Res; 2008 Aug; 643(1-2):4-10. PubMed ID: 18573508
[TBL] [Abstract][Full Text] [Related]
64. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.
Miller DP; De Vivo I; Neuberg D; Wain JC; Lynch TJ; Su L; Christiani DC
Int J Cancer; 2003 May; 104(6):758-63. PubMed ID: 12640684
[TBL] [Abstract][Full Text] [Related]
65. GSTT1 and GSTM1 polymorphism in cigarette smokers with head and neck squamous cell carcinoma.
Biselli JM; de Angelo Calsaverini Leal RC; Ruiz MT; Goloni-Bertollo EM; Maníglia JV; Rossit AR; Pavarino-Bertelli EC
Braz J Otorhinolaryngol; 2006; 72(5):654-8. PubMed ID: 17221058
[TBL] [Abstract][Full Text] [Related]
66. Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer.
Van Emburgh BO; Hu JJ; Levine EA; Mosley LJ; Perrier ND; Freimanis RI; Allen GO; Rubin P; Sherrill GB; Shaw CS; Carey LA; Sawyer LR; Miller MS
Oncol Rep; 2008 May; 19(5):1311-21. PubMed ID: 18425393
[TBL] [Abstract][Full Text] [Related]
67. GSTT1, GSTM1, and CYP1B1 gene polymorphisms and susceptibility to sporadic renal cell cancer.
Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Serrano-Oviedo L; Gimenez-Bachs JM; Martínez-Sanchiz C; Segura-Martín M; Escribano J
Urol Oncol; 2012; 30(6):864-70. PubMed ID: 21458313
[TBL] [Abstract][Full Text] [Related]
68. Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy.
Cabelguenne A; Loriot MA; Stucker I; Blons H; Koum-Besson E; Brasnu D; Beaune P; Laccourreye O; Laurent-Puig P; De Waziers I
Int J Cancer; 2001 Sep; 93(5):725-30. PubMed ID: 11477586
[TBL] [Abstract][Full Text] [Related]
69. Interaction of glutathione-s-transferase genotypes with environmental risk factors in determining susceptibility to head and neck cancer and treatment response and survival outcome.
Katiyar T; Yadav V; Maurya SS; Ruwali M; Singh M; Hasan F; Pandey R; Mehrotra D; Singh S; Mishra S; Hadi R; Bhatt MLB; Parmar D
Environ Mol Mutagen; 2020 Jun; 61(5):574-584. PubMed ID: 32067264
[TBL] [Abstract][Full Text] [Related]
70. Independent and Interactive Effect of CYPs and GSTs Genetic Variants and Tobacco Smoking on the Risk of Non-Small Cell Lung Carcinoma.
Pathak AK; Husain N; Kant S; Bala L
Arch Med Res; 2021 Oct; 52(7):719-730. PubMed ID: 34092421
[TBL] [Abstract][Full Text] [Related]
71. Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response.
Yadav SS; Ruwali M; Shah PP; Mathur N; Singh RL; Pant MC; Parmar D
Mutat Res; 2008 Sep; 644(1-2):31-7. PubMed ID: 18644391
[TBL] [Abstract][Full Text] [Related]
72. Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer?
Gronau S; Koenig-Greger D; Jerg M; Riechelmann H
Otolaryngol Head Neck Surg; 2003 May; 128(5):674-80. PubMed ID: 12748560
[TBL] [Abstract][Full Text] [Related]
73. Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population.
Honma HN; De Capitani EM; Perroud MW; Barbeiro AS; Toro IF; Costa DB; Lima CS; Zambon L
Lung Cancer; 2008 Aug; 61(2):152-62. PubMed ID: 18280004
[TBL] [Abstract][Full Text] [Related]
74. Polymorphic metabolic susceptibility genes and longevity: a study in octogonarians.
Pesch B; Düsing R; Rabstein S; Harth V; Grentrup D; Brüning T; Landt O; Vetter H; Ko YD
Toxicol Lett; 2004 Jun; 151(1):283-90. PubMed ID: 15177664
[TBL] [Abstract][Full Text] [Related]
75. Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers.
Sikdar N; Paul RR; Roy B
Int J Cancer; 2004 Mar; 109(1):95-101. PubMed ID: 14735473
[TBL] [Abstract][Full Text] [Related]
76. Polymorphisms of GSTT1 and related genes in head and neck cancer risk.
Evans AJ; Henner WD; Eilers KM; Montalto MA; Wersinger EM; Andersen PE; Cohen JI; Everts EC; McWilliams JE; Beer TM
Head Neck; 2004 Jan; 26(1):63-70. PubMed ID: 14724908
[TBL] [Abstract][Full Text] [Related]
77. Association between exposure-relevant polymorphisms in CYP1B1, EPHX1, NQO1, GSTM1, GSTP1 and GSTT1 and risk of colorectal cancer in a Czech population.
Hlavata I; Vrana D; Smerhovsky Z; Pardini B; Naccarati A; Vodicka P; Novotny J; Mohelnikova-Duchonova B; Soucek P
Oncol Rep; 2010 Nov; 24(5):1347-53. PubMed ID: 20878130
[TBL] [Abstract][Full Text] [Related]
78. Gene-environment interactions in determining differences in genetic susceptibility to cancer in subsites of the head and neck.
Maurya SS; Katiyar T; Dhawan A; Singh S; Jain SK; Pant MC; Parmar D
Environ Mol Mutagen; 2015 Apr; 56(3):313-21. PubMed ID: 25399842
[TBL] [Abstract][Full Text] [Related]
79. Association between GSTM1 and GSTT1 allelic variants and head and neck squamous cell cancinoma.
Zhang Y; Ni Y; Zhang H; Pan Y; Ma J; Wang L
PLoS One; 2012; 7(10):e47579. PubMed ID: 23077643
[TBL] [Abstract][Full Text] [Related]
80. Genetic polymorphisms in head and neck cancer risk.
McWilliams JE; Evans AJ; Beer TM; Andersen PE; Cohen JI; Everts EC; Henner WD
Head Neck; 2000 Sep; 22(6):609-17. PubMed ID: 10941163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
